Dow Down 0.25% Nasdaq Down 0.26%

More On VSTA

Quotes

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

VistaGen Therapeutics, Inc. (VSTA)

-Other OTC
0.60 Aug 11, 3:21PM EDT
|Pre-Market : NaN
Prev Close:0.60
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:1.631
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.25 - 0.89
Volume:0
Avg Vol (3m):3,723
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-0.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VistaGen Therapeutics, Inc., a biotechnology company, focuses on application and development of proprietary human pluripotent stem cell technology for drug rescue and regenerative medicine in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback